Swiss (SMI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 23, 2025

Explore the Swiss (SMI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
SDZ Sandoz Group	CHF 50.22	2.0%	33.8%	CHF 21.6b	CHF 49.03	PE118.9x	E27.9%	1.1%
SFZN Siegfried Holding	CHF 86.10	1.7%	-22.3%	CHF 3.8b	CHF 111.57	PE24.5x	E10.9%	0.4%
IDIA Idorsia	CHF 2.69	10.7%	18.5%	CHF 549.0m	CHF 2.00	PS2.5x	E45.1%	n/a
COPN Cosmo Pharmaceuticals	CHF 58.00	4.9%	-27.3%	CHF 924.5m	CHF 88.37	PE16.4x	E34.4%	3.3%
TECN Tecan Group	CHF 174.20	1.2%	-39.1%	CHF 2.2b	CHF 220.47	PE35x	E15.6%	1.7%
DESN Dottikon ES Holding	CHF 294.50	0.5%	12.0%	CHF 4.1b	CHF 357.63	PE38.5x	S12.7%	0%
PPGN PolyPeptide Group	CHF 28.20	1.3%	-18.0%	CHF 930.4m	CHF 31.30	PS2.7x	E88.0%	0%
MOLN Molecular Partners	CHF 2.98	2.4%	-43.2%	CHF 99.5m	CHF 9.50	PS44.6x	E-5.6%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 14.48	0.8%	60.9%	CHF 186.4m	CHF 30.00	PS4.8x	S48.7%	n/a
RLF Relief Therapeutics Holding	CHF 2.70	1.7%	153.5%	CHF 34.0m	n/a	PS8.4x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.057	4.4%	2.5%	CHF 5.6m	n/a	PS22.9x	E-11.9%	n/a
SKAN SKAN Group	CHF 68.00	0%	-15.0%	CHF 1.5b	CHF 88.33	PE94.5x	E23.4%	0.3%
CURN Curatis Holding	CHF 11.05	0%	121.0%	CHF 55.2m	CHF 84.50	n/a	n/a	n/a
BSLN Basilea Pharmaceutica	CHF 47.45	-0.1%	5.0%	CHF 582.8m	CHF 81.34	PE8x	E7.5%	0%
XLS Xlife Sciences	CHF 20.80	-1.4%	-23.2%	CHF 119.4m	n/a	PE3.5x	n/a	n/a
NWRN Newron Pharmaceuticals	CHF 7.63	-2.2%	-2.9%	CHF 152.3m	CHF 18.20	PE10.2x	E42.8%	n/a
BIOV BioVersys	CHF 24.50	-2.4%	n/a	CHF 142.7m	CHF 60.00	PS117.6x	E-14.9%	n/a
BANB Bachem Holding	CHF 67.80	-0.4%	-17.5%	CHF 5.1b	CHF 77.88	PE37.9x	E17.2%	1.3%
LONN Lonza Group	CHF 566.60	-0.07%	1.3%	CHF 40.0b	CHF 665.36	PE54.6x	E20.5%	0.7%
KURN Kuros Biosciences	CHF 26.92	-3.2%	76.9%	CHF 1.0b	CHF 31.00	PS10x	E54.2%	n/a
GALD Galderma Group	CHF 135.30	-0.9%	62.9%	CHF 32.1b	CHF 140.69	PE106.1x	E32.0%	0.1%
ROG Roche Holding	CHF 261.50	-0.4%	-7.7%	CHF 224.3b	CHF 298.64	PE23.6x	E13.4%	3.7%
NOVN Novartis	CHF 101.96	-0.9%	1.6%	CHF 197.4b	CHF 99.01	PE18x	E8.0%	3.0%